Akums Drugs and Pharmaceuticals Limited (BOM:544222)
India flag India · Delayed Price · Currency is INR
750.00
-3.20 (-0.42%)
At close: Aug 21, 2026

BOM:544222 Stock Forecast

Stock Price Forecast

According to 3 analysts polled by S&P Global, BOM:544222 stock has a consensus rating of "Strong Buy" and an average price target of ₹780.00. The average 1-year stock price forecast is 4.00% higher than the current stock price, while the lowest is ₹610.00 (-18.67%) and the highest is ₹880.00 (+17.33%).

Price Target: ₹780.00 (+4.00%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price₹610.00₹780.00₹850.00₹880.00
Change-18.67%+4.00%+13.33%+17.33%

Analyst Ratings

The average analyst rating for BOM:544222 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingFeb '26Mar '26Apr '26May '26Jul '26Aug '26
Strong Buy333333
Buy000000
Hold000000
Sell000000
Strong Sell000000
Total333333

Financial Forecast

Revenue This Year
50.25B
from 43.61B
Increased by 15.21%
Revenue Next Year
57.80B
from 50.25B
Increased by 15.04%
EPS This Year
27.23
from 17.55
Increased by 55.17%
EPS Next Year
34.13
from 27.23
Increased by 25.35%
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingMar 31, 2022Mar 31, 2023Mar 31, 2024Mar 31, 2025Mar 31, 2026Mar 31, 2027
Revenue
36.75B36.57B41.82B41.21B43.61B50.25B
Revenue Growth
34.81%-0.49%14.34%-1.45%5.84%15.21%
Gross Profit
12.61B13.08B15.61B16.22B17.72B21.98B
Gross Margin
34.30%35.76%37.34%39.35%40.62%43.75%
Operating Income
3.16B1.89B3.59B3.10B3.70B5.81B
Net Income
-2.53B948.55M-40.35M3.38B2.55B4.24B
EPS
----17.5527.23
EPS Growth
-----18.34%55.17%
Forward PE
-----27.54
Dividend / Share
----1.00-
Free Cash Flow
-2.55B-1.95B760.05M354.70M932.99M1.33B
No. Analysts
-----3
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.

Revenue Forecast

Revenue202720282029
High50.6B
Avg50.2B
Low50.0B

Revenue Growth

Revenue Growth202720282029
High
16.1%
Avg
15.2%
Low
14.7%

EPS Forecast

EPS202720282029
High28.50
Avg27.23
Low26.20

EPS Growth

EPS Growth202720282029
High
62.4%
Avg
55.2%
Low
49.3%